NetScientific - Clinical and commercial progress continues
In January Glycotest announced that it had completed a 149-person Chinese retrospective study of its test for hepatocellular carcinoma (HCC). It...
134 Views
NetScientific - Commercial progress across portfolio
Within the month of November 2017, NetScientific portfolio companies had a series of announcements reflecting increased adoption of their products....
66 Views
Progress continues
NetScientific’s healthcare portfolio progressed towards revenue generation during H117 with the soft launch of both Vortex and ProAxsis products...
81 Views
PDS collaborates with Merck
One of NetScientific’s portfolio companies, PDS Biotechnology (17.4% stake, 14.5% fully diluted), announced on 10 July 2017 that it has entered...
47 Views
Portfolio starting to mature
The NetScientific portfolio steadily marches forward with an increasing number of companies with significant revenue on the horizon. Wanda and...
51 Views